Viridian Therapeutics Inc (VRDN) Insider Trading
- $50,878,085.50
- $6,517,369.80
- Sept. 27, 2024
- Lara Meisner
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 27, 2024 | CEO | 21,400 | $23.33 | Buy | $499,262.00 | |
| Sept. 27, 2024 | COO | 5,000 | $23.41 | Buy | $117,050.00 | |
| Sept. 13, 2024 | Director | 1,600,000 | $18.75 | Buy | $30,000,000.00 | |
| Jan. 22, 2024 | Director | 476,190 | $21.00 | Buy | $9,999,990.00 | |
| June 15, 2023 | Insider | 2,269 | $28.02 | Sell | $63,577.38 | |
| June 5, 2023 | Insider | 499 | $25.03 | Sell | $12,489.97 | |
| June 2, 2023 | Insider | 1,875 | $24.21 | Sell | $45,393.75 | |
| April 12, 2023 | CEO | 4,000 | $25.37 | Buy | $101,480.00 | |
| March 13, 2023 | CEO | 5,500 | $29.15 | Buy | $160,325.00 | |
| March 9, 2023 | General Counsel | 29,971 | $29.07 | Sell | $871,256.97 | |
| Feb. 2, 2023 | Insider | 50,000 | $36.80 | Sell | $1,840,000.00 | |
| Jan. 23, 2023 | General Counsel | 6,843 | $35.66 | Sell | $244,021.38 | |
| Jan. 17, 2023 | insider | 24,853 | $37.21 | Sell | $924,780.13 | |
| Jan. 13, 2023 | insider | 4,147 | $37.01 | Sell | $153,480.47 | |
| Jan. 10, 2023 | insider | 47,377 | $35.30 | Sell | $1,672,408.10 | |
| Dec. 20, 2022 | General Counsel | 600 | $28.07 | Sell | $16,842.00 | |
| Dec. 16, 2022 | General Counsel | 1,297 | $28.44 | Sell | $36,886.68 | |
| Dec. 14, 2022 | General Counsel | 15,656 | $28.12 | Sell | $440,246.72 | |
| Dec. 12, 2022 | General Counsel | 600 | $28.05 | Sell | $16,830.00 | |
| Nov. 15, 2022 | General Counsel | 8,125 | $22.05 | Sell | $179,156.25 | |
| Aug. 17, 2022 | Director | 425,531 | $23.50 | Buy | $9,999,978.50 |
Insiders are both buying and selling Viridian Therapeutics Inc stock.
The insider traders at Viridian Therapeutics Inc are: Lara Meisner, Fairmount Funds Management Llc, Barrett Katz, Scott Dunseth Myers, Jonathan Violin, Stephen F Mahoney, and Thomas W Beetham
The most active insider trader at Viridian Therapeutics Inc is Lara Meisner with 10 trades.
Jonathan Violin has sold the most Viridian Therapeutics Inc stock with a total value of $3,680,000.00.
Fairmount Funds Management Llc has bought the most Viridian Therapeutics Inc stock with a total value of $79,999,968.50.
The most recent insider trade for Viridian Therapeutics Inc was on Sept. 27, 2024.
The single biggest insider buy for Viridian Therapeutics Inc was from Fairmount Funds Management Llc with a total value of $30,000,000.00 on Sept. 13, 2024.
The single biggest insider sell for Viridian Therapeutics Inc was from Jonathan Violin with a total value of $1,840,000.00 on Feb. 2, 2023.